Actinium Pharma
ATNM----
Forecast & Rating4 analysts currently cover Actinium Pharma, of which 3 give a positive rating. The average price target is $4.00, about 185.7% upside from the current price of $1.40. Coverage is limited, so the data is for reference only. Data as of Oct 23, 2026; this does not constitute investment advice.
Oct 23, 2026Price forecast
$4.00185.71%
Forecast & RatingStrong buy
3analysts
- Strong buy66.67%
- Buy33.33%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateOct 26, 2026
Forecast met0.0%
Stock price$1.40
Avg. target$5.0
High target$9
Low target$2
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.